AI-Enhanced Multifocal Intraocular Lens System

A novel system integrating multifocal intraocular lenses with artificial intelligence, IoT, blockchain, and novel materials to enhance visual performance, predict and prevent complications, and provide secure data storage and sharing.

The original multifocal intraocular lens patent addressed the need for restoring visual function and achieving eyeglasses independence after cataract or myopia treatment. However, the existing technology has limitations in terms of adapting to individual patient needs and monitoring visual performance in real-time. The new inventive concept addresses these limitations by integrating the patented inventive concept with distinct technologies to create a more powerful and adaptive system.

The AI-Enhanced Multifocal Intraocular Lens System comprises a multifocal intraocular lens integrated with an artificial intelligence module that monitors and adapts diffractive orders based on a patient's visual performance data. The system also utilizes machine learning algorithms and sensor data from an IoT-enabled eye tracker to optimize diffractive profiles. Additionally, the system features a blockchain-secured digital twin for secure storage and sharing of patient-specific data and treatment plans. Furthermore, the system predicts and prevents post-operative complications using predictive analytics and real-time monitoring via IoT-enabled sensors. The system also enables the design and manufacture of customized multifocal intraocular lenses using novel materials and 3D printing technology, optimized for specific patient needs and visual performance.

The new claims introduce the innovative integration of multifocal intraocular lenses with artificial intelligence, IoT, blockchain, and novel materials, which is not obvious from the original patent. The inventive concept's adaptability, real-time monitoring, and secure data storage features provide a significant improvement over existing technologies.

Alternative embodiments of the inventive concept could include integrating the multifocal intraocular lens with other AI-powered modules, such as natural language processing or computer vision, to further enhance visual performance and patient experience. Variations of the system could also include using different types of sensors or data analytics platforms to optimize diffractive profiles and predict complications.

The AI-Enhanced Multifocal Intraocular Lens System has significant commercial potential in the ophthalmology industry, particularly in the areas of cataract and myopia treatment. The system's ability to provide real-time monitoring, adaptability, and secure data storage makes it an attractive solution for healthcare providers and patients alike. The market for this technology is expected to grow significantly in the coming years, driven by the increasing demand for advanced ophthalmic treatments and the need for more efficient and effective healthcare solutions.